Specific Na+/K+-ATPase inhibitor.
Product Details
| Alternative Name: | (3β,5β,15β)-14,15-Epoxy-3-hydroxy-5-bufa-20,22-dienolide |
| |
| Formula: | C24H32O4 |
| |
| MW: | 384.5 |
| |
| Source: | Isolated from Bufonis venom. |
| |
| CAS: | 465-39-4 |
| |
| MI: | 14: 8146 |
| |
| RTECS: | EI2975000 |
| |
| Purity: | ≥98% (HPLC) |
| |
| Identity: | Determined by MS. |
| |
| Appearance: | White to off-white solid. |
| |
| Solubility: | Soluble in chloroform. |
| |
| Shipping: | Ambient Temperature |
| |
| Long Term Storage: | +4°C |
| |
| Regulatory Status: | RUO - Research Use Only |
| |
Please mouse over
Product Literature References
Resibufogenin corrects hypertension in a rat model of human preeclampsia: H. Vu, et al.; Exp. Biol. Med. (Maywood)
231, 215 (2006),
Abstract;
Effects of resibufogenin from toad venom on isolated Purkinje fibers: J.T. Xie, et al.; Am. J. Chin. Med.
28, 187 (2000),
Abstract;
